跳至主要内容
临床试验/NCT03755856
NCT03755856Unknown不适用

A Survivorship Project to UnerstAnd and to impRove Long-Term Outcomes for Acute Myeloid Leukemia Patients (SPARTA): the Sparta Platform

Gruppo Italiano Malattie EMatologiche dell'Adulto39 个研究点 分布在 8 个国家目标入组 343 人开始时间: 2019年5月16日最近更新:
适应症

试验速览

阶段
不适用
入组人数
343
试验地点
39
主要终点
Number of differences in SF-36 scores

研究概览

简要总结

This international observational study aims at examining the patterns of health-related quality of life differences between long-term acute myeloid leukemia patients and their healthy peers from the general population.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of all subtypes of de novo AML, according to WHO criteria (at least 20% blasts in the bone marrow), except acute promyelocytic leukemia (APL).
  • Age at AML diagnosis ≥ 18 years,
  • Date of AML diagnosis at least 5 years before study enrollment,
  • AML-free status at study enrollment,
  • Written informed consent provided.

排除标准

  • Major cognitive deficit or psychiatric problems hampering a self-reported evaluation,
  • Not speaking and reading the language of the participating country,
  • More than 75 years at the time of study enrollment,
  • Receiving any active treatment for AML at the time of study enrollment.

结局指标

主要结局

Number of differences in SF-36 scores

时间窗: At enrollment

The Role Physical scores of AML survivors will be compared to that in the general population as assessed by SF-36 questionnaire. Comparisons will be performed on age-sex matched pairs of AML patients and healthy subjects from the general population.

次要结局

  • Outcomes from SF-36 questionnaire will be described and compared between AML patients from RCTs vs non RCTs.(At enrollment)
  • Outcomes from SCQ questionnaire will be described and compared between AML patients from RCTs vs non RCTs.(At enrollment)
  • Outcomes from EORTC QLQ-C30 questionnaire will be described and compared between AML patients from RCTs vs non RCTs.(At enrollment)
  • QoL profiles of AML survivors will be compared with those in the general population also as assessed by EORTC QLQ-C30 questionnaire.(At enrollment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (39)

Loading locations...

相似试验